Clin Chem Lab Med. 2014 Jun;52(6):815-24. doi: 10.1515/cclm-2013-0741.
The performance of creatinine-based glomerular filtration rate (GFR) estimating equations may vary in subgroups defined by GFR, age and body mass index (BMI). This study compares the performance of the Modification of Diet in Renal Disease (MDRD) study and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations with the revised Lund-Malmö equation (LM Revised), a new equation that can be expected to handle changes in GFR across the life span more accurately.
The study included 3495 examinations in 2847 adult Swedish patients referred for measurement of GFR (mGFR) 2008-2010 by plasma clearance of iohexol (median 52 mL/min/1.73 m²). Bias, precision [interquartile range (IQR)] and accuracy [percentage of estimates ±10% (P₁₀) and ±30% (P₃₀) of mGFR] were compared.
The overall results of LM Revised/MDRD/CKD-EPI were: median bias 2%/8%/11%, IQR 12/14/14 mL/min/1.73 m², P₁₀ 40%/35%/35% and P₃₀ 84%/75%/76%. LM Revised was the most stable equation in terms of bias, precision and accuracy across mGFR, age and BMI intervals irrespective of gender. MDRD and CKD-EPI overestimated mGFR in patients with decreased kidney function, young adults and elderly. All three equations overestimated mGFR and had low accuracy in patients with BMI <20 kg/m², most pronounced among men.
In settings similar to the investigated cohort LM Revised should be preferred to MDRD and CKD-EPI due to its higher accuracy and more stable performance across GFR, age and BMI intervals.
基于肌酐的肾小球滤过率(GFR)估算方程的性能可能因 GFR、年龄和体重指数(BMI)定义的亚组而有所不同。本研究比较了改良肾脏病饮食研究(MDRD)方程和慢性肾脏病流行病学合作组(CKD-EPI)方程与新方程 Lund-Malmö 修订版(LM 修订版)的性能,新方程有望更准确地处理整个生命周期中 GFR 的变化。
该研究纳入了 2008 年至 2010 年期间 2847 名瑞典成年患者的 3495 次检查,这些患者因 GFR(mGFR)测定而接受了血浆 iohexol 清除率检查(中位数 52 mL/min/1.73 m²)。比较了偏倚、精度[四分位距(IQR)]和准确性[估计值的百分比±10%(P₁₀)和±30%(P₃₀)的 mGFR]。
LM 修订版/MDRD/CKD-EPI 的总体结果为:中位数偏倚为 2%/8%/11%,IQR 为 12/14/14 mL/min/1.73 m²,P₁₀ 为 40%/35%/35%,P₃₀ 为 84%/75%/76%。无论性别如何,LM 修订版在整个 mGFR、年龄和 BMI 范围内均具有最稳定的方程,在偏倚、精度和准确性方面。MDRD 和 CKD-EPI 高估了肾功能下降、年轻成年人和老年人的 mGFR。所有三种方程都高估了 BMI<20 kg/m²的患者的 mGFR,其中男性最为明显。
在与研究队列相似的环境中,由于 LM 修订版具有更高的准确性和更稳定的 GFR、年龄和 BMI 性能,因此应优先选择 MDRD 和 CKD-EPI。